Cargando…
Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children
IMPORTANCE: Optimal agents and duration of primary treatment for multisystem inflammatory syndrome in children (MIS-C) remain unclear. OBJECTIVE: To compare short-term patient outcomes based on initial treatment with corticosteroids, intravenous immunoglobulin (IVIG), or both. DESIGN, SETTING, AND P...
Autores principales: | Villacis-Nunez, D. Sofia, Jones, Kaitlin, Jabbar, Aysha, Fan, Lucie, Moore, Whitney, Peter, Andrew S., Henderson, Michaela, Xiang, Yijin, Kelleman, Michael S., Sherry, Whitney, Chandrakasan, Shanmuganathan, Oster, Matthew E., Jaggi, Preeti, Prahalad, Sampath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961405/ https://www.ncbi.nlm.nih.gov/pubmed/35344042 http://dx.doi.org/10.1001/jamapediatrics.2022.0292 |
Ejemplares similares
-
Giant Coronary Aneurysms in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection
por: Villacis-Nunez, D. Sofia, et al.
Publicado: (2021) -
Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)
por: Kumar, Deepak, et al.
Publicado: (2022) -
Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases
por: Villacis-Nunez, D. Sofia, et al.
Publicado: (2021) -
Intravenous administration of anakinra in children with macrophage activation syndrome
por: Phadke, Omkar, et al.
Publicado: (2021) -
Delayed Coronary Dilation with Multisystem Inflammatory Syndrome in Children
por: Nelson, Meghan Corrigan, et al.
Publicado: (2021)